Lars C. Wallentin
Uppsala University
3 papers in the Anchorcite directory, published between 2009 and 2011, cited 27,539 times in total.
ORCID profileResearch topics
- Acute Ischemic Stroke Management · 2 papers
- Atrial Fibrillation Management and Outcomes · 2 papers
- Venous Thromboembolism Diagnosis and Management · 2 papers
- Acute Myocardial Infarction Research · 1 paper
- Antiplatelet Therapy and Cardiovascular Diseases · 1 paper
- Coronary Interventions and Diagnostics · 1 paper
Frequent co-authors
- Jun Zhu · 2 papers
- Rafael Díaz · 2 papers
- Basil S. Lewis · 2 papers
- Stuart J. Connolly · 1 paper
- Michael D. Ezekowitz · 1 paper
- Salim Yusuf · 1 paper
- John W. Eikelboom · 1 paper
- Jonas Oldgren · 1 paper
Papers
- Dabigatran versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine · 2009 · 11,314 citations
BACKGROUND: Warfarin reduces the risk of stroke in patients with atrial fibrillation but increases the risk of hemorrhage and is difficult to use. Dabigatran is a new oral direct thrombin inhibitor. METHODS: In this noninferiority trial, we randomly assigned 18,113…
- Apixaban versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine · 2011 · 9,052 citations
BACKGROUND: Vitamin K antagonists are highly effective in preventing stroke in patients with atrial fibrillation but have several limitations. Apixaban is a novel oral direct factor Xa inhibitor that has been shown to reduce the risk of stroke in a…
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary SyndromesNew England Journal of Medicine · 2009 · 7,173 citations
BACKGROUND: Ticagrelor is an oral, reversible, direct-acting inhibitor of the adenosine diphosphate receptor P2Y12 that has a more rapid onset and more pronounced platelet inhibition than clopidogrel. METHODS: In this multicenter, double-blind, randomized trial, we compared ticagrelor (180-mg loading dose,…
Metadata from OpenAlex (CC0).